Last reviewed · How we verify

NCT03684421

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol

Status unknown Last updated 8 October 2020
What this trial tests

trial testing Pregnancy Rate in Pregnancy, Ovarian in 120 participants. Status unknown.

Timeline
15 February 2017
Primary endpoint
30 June 2021
30 June 2021

Quick facts

Lead sponsorAssisting Nature
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date15 February 2017
Primary completion30 June 2021
Estimated completion30 June 2021
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Assisting Nature

Who can join

Adults 18 to 39, female only, with Pregnancy, Ovarian. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized prospective study of the evaluation of the clinical IVF results after following Long Antagonist protocol for controlled ovarian stimulation versus following classical antagonist protocol

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pregnancy Rate

Trials testing the same drug.

Other Assisting Nature trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing